EASL Clinical Practice Guidelines on the management of liver diseases in pregnancy
Copyright © 2023 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved..
Liver diseases in pregnancy comprise both gestational liver disorders and acute and chronic hepatic disorders occurring coincidentally in pregnancy. Whether related to pregnancy or pre-existing, liver diseases in pregnancy are associated with a significant risk of maternal and fetal morbidity and mortality. Thus, the European Association for the Study of Liver Disease invited a panel of experts to develop clinical practice guidelines aimed at providing recommendations, based on the best available evidence, for the management of liver disease in pregnancy for hepatologists, gastroenterologists, obstetric physicians, general physicians, obstetricians, specialists in training and other healthcare professionals who provide care for this patient population.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2023 |
|---|---|
| Erschienen: |
2023 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:79 |
|---|---|
| Enthalten in: |
Journal of hepatology - 79(2023), 3 vom: 30. Sept., Seite 768-828 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Contraception |
|---|
| Anmerkungen: |
Date Completed 22.08.2023 Date Revised 16.11.2023 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.jhep.2023.03.006 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM358952441 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM358952441 | ||
| 003 | DE-627 | ||
| 005 | 20231226075832.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2023 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.jhep.2023.03.006 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1196.xml |
| 035 | |a (DE-627)NLM358952441 | ||
| 035 | |a (NLM)37394016 | ||
| 035 | |a (PII)S0168-8278(23)00181-2 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 0 | |a European Association for the Study of the Liver. Electronic address: easloffice@easloffice.eu |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a EASL Clinical Practice Guidelines on the management of liver diseases in pregnancy |
| 264 | 1 | |c 2023 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 22.08.2023 | ||
| 500 | |a Date Revised 16.11.2023 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2023 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved. | ||
| 520 | |a Liver diseases in pregnancy comprise both gestational liver disorders and acute and chronic hepatic disorders occurring coincidentally in pregnancy. Whether related to pregnancy or pre-existing, liver diseases in pregnancy are associated with a significant risk of maternal and fetal morbidity and mortality. Thus, the European Association for the Study of Liver Disease invited a panel of experts to develop clinical practice guidelines aimed at providing recommendations, based on the best available evidence, for the management of liver disease in pregnancy for hepatologists, gastroenterologists, obstetric physicians, general physicians, obstetricians, specialists in training and other healthcare professionals who provide care for this patient population | ||
| 650 | 4 | |a Practice Guideline | |
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Contraception | |
| 650 | 4 | |a Delivery | |
| 650 | 4 | |a Gestational liver disease | |
| 650 | 4 | |a Guideline | |
| 650 | 4 | |a Liver disease | |
| 650 | 4 | |a Medications in pregnancy | |
| 650 | 4 | |a Pre-existing liver disease | |
| 650 | 4 | |a Pre-pregnancy counselling | |
| 650 | 4 | |a Pregnancy | |
| 700 | 0 | |a European Association for the Study of the Liver |e verfasserin |4 aut | |
| 700 | 1 | |a Williamson, Catherine |e investigator |4 oth | |
| 700 | 1 | |a Nana, Melanie |e investigator |4 oth | |
| 700 | 1 | |a Poon, Liona |e investigator |4 oth | |
| 700 | 1 | |a Kupcinskas, Limas |e investigator |4 oth | |
| 700 | 1 | |a Painter, Rebecca |e investigator |4 oth | |
| 700 | 1 | |a Taliani, Gloria |e investigator |4 oth | |
| 700 | 1 | |a Heneghan, Michael |e investigator |4 oth | |
| 700 | 1 | |a Marschall, Hanns-Ulrich |e investigator |4 oth | |
| 700 | 1 | |a Beuers, Ulrich |e investigator |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t Journal of hepatology |d 1993 |g 79(2023), 3 vom: 30. Sept., Seite 768-828 |w (DE-627)NLM012604372 |x 1600-0641 |7 nnns |
| 773 | 1 | 8 | |g volume:79 |g year:2023 |g number:3 |g day:30 |g month:09 |g pages:768-828 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.jhep.2023.03.006 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 79 |j 2023 |e 3 |b 30 |c 09 |h 768-828 | ||